<p>Intravitreal (Adult)-<br />
<br />
<strong>Neovascular (wet) age-related macular degeneration:</strong>&nbsp;0.5 mg mthly into the affected eye as a single dose. Continue treatment until visual acuity is stable for 3 consecutive mth. Doses are given at intervals of at least 1 mth.<br />
<br />
<strong>Choroidal neovascularisation secondary to pathologic myopia</strong>: 0.5 mg into the affected eye as a single dose. Further injections may be given if monitoring reveals signs of disease activity (1-2 inj during the 1st yr; some patients may need more frequent treatment). Doses are given at intervals of at least 1 mth.<br />
<br />
<strong>Diabetic macular oedema, Macular oedema secondary to retinal vein occlusion</strong>: 0.5 mg mthly into the affected eye as a single dose. Continue treatment until visual acuity is stable for 3 consecutive mth. Doses are given at intervals of at least 1 mth. Discontinue treatment if no improvement in visual acuity after 3 initial inj.</p>